Human Research Switzerland Human Research Switzerland
Legal Notice & Data Protection
Contact & Impressum
DE
|
FR
|
EN

Note: This search will not find any studies.

Start study search
Loading...
Your search returned results.
of pages
No results found for ""
Back to search results
General information
  • Disease category Periodontal diseases (BASEC)
  • Recruitment status recruitment temporarily on hold (BASEC/ICTRP)
  • Trial sites
    Bern
    (BASEC)
  • Contact Stefanie Wolf-Zbinden Stefanie.wolf@geistlich.com (BASEC)
  • Data Source(s) BASEC: Import from 10.04.2025 ICTRP: N/A
  • Last update 10.04.2025 15:45
HumRes65156 | SNCTP000005954 | BASEC2023-D0120

First experiences with the effectiveness of Geistlich Bio-Oss® Flow (fDBBM-C) in cases of bone defects in the jaw area due to inflammation of the gums in the area of the periodontal apparatus

  • Disease category Periodontal diseases (BASEC)
  • Recruitment status recruitment temporarily on hold (BASEC/ICTRP)
  • Trial sites
    Bern
    (BASEC)
  • Contact Stefanie Wolf-Zbinden Stefanie.wolf@geistlich.com (BASEC)
  • Data Source(s) BASEC: Import from 10.04.2025 ICTRP: N/A
  • Last update 10.04.2025 15:45

Summary description of the study

In this study, we investigate the effectiveness of the medical device Geistlich Bio-Oss® Flow in patients with jaw bone defects due to periodontitis. The study takes place at a single center in Switzerland. All patients are treated with Geistlich Bio-Oss® Flow. The duration of study participation is approximately 6 months.

(BASEC)

Intervention under investigation

surgical intervention for jaw bone reconstruction in patients with periodontitis

(BASEC)

Disease under investigation

chronic inflammatory disease of the periodontal apparatus (periodontitis)

(BASEC)

Criteria for participation in trial
-Patients with a periodontal jaw bone defect (defect depth greater than 3 mm) -Good oral hygiene -Adults 18 years or older (BASEC)

Exclusion criteria
-Active or chronic infections at the surgical site -Clinical condition/treatment affecting tissue healing -Pregnant or nursing women (BASEC)

Trial sites

Bern

(BASEC)

not available

Sponsor

Geistlich Pharma AG

(BASEC)

Contact

Contact Person Switzerland

Stefanie Wolf-Zbinden

+41 41 492 68 24

Stefanie.wolf@geistlich.com

Geistlich Pharma AG Bahnhofstrasse 40 6110 Wolhusen

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethics Committee Bern

(BASEC)

Date of authorisation

22.05.2024

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
First experience with the performance of Geistlich Bio-Oss® Flow (fDBBM-C) in periodontal intrabony defects (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available